Mountain View Hospital LLC

Mountain View Hospital LLC was paid $45.73M by Medicaid between Jan 2018 and Dec 2024, across 289 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 22% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	183,405	$12.01M
2019	195,503	$12.90M
2020	118,534	$6.83M
2021	43,776	$2.58M
2022	66,398	$3.92M
2023	67,448	$3.73M
2024incomplete	64,066	$3.77M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
97530	Therapeutic activities, direct patient contact, each 15 minutes	22%	88,387	21,049	$10.01M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	21%	146,840	33,519	$9.48M
T1015	A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive	13%	35,811	33,628	$6.09M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	107,332	97,797	$5.83M
41899	Unlisted procedure, dentoalveolar structures	6.4%	1,780	1,762	$2.94M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.4%	67,297	63,371	$2.47M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.5%	17,408	4,913	$1.14M
00170	Anesthesia for intraoral procedures, including biopsy	1.2%	4,336	4,308	$569K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	5,721	5,191	$443K
92523		<1%	3,155	3,119	$431K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	3,343	3,321	$374K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	395	392	$312K

277 more codes

64493		<1%	629	$303K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	354	$278K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,350	$278K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,566	$264K
99203	Doctor's office visit, new patient (routine)	<1%	3,849	$257K
64483		<1%	597	$218K
64636		<1%	478	$194K
62323		<1%	911	$190K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	28,619	$182K
64635		<1%	407	$175K
76942		<1%	12,215	$169K
20553		<1%	6,551	$160K
97166		<1%	1,665	$117K
97113		<1%	1,122	$103K
64494		<1%	598	$103K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,962	$99K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	1,421	$90K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	2,058	$85K
87428		<1%	1,556	$84K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	2,858	$79K
64640		<1%	175	$71K
80053	Comprehensive metabolic panel	<1%	11,504	$69K
J0897	Injection, denosumab, 1 mg	<1%	100	$67K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,908	$64K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	854	$63K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	13,550	$62K
J1453	Injection, fosaprepitant, 1 mg	<1%	291	$58K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,537	$57K
64490		<1%	102	$51K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	440	$50K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	342	$45K
99152		<1%	2,907	$44K
97162		<1%	610	$40K
97116		<1%	1,167	$39K
84443	Thyroid stimulating hormone (TSH)	<1%	3,393	$39K
27096		<1%	283	$39K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	286	$37K
92526		<1%	629	$36K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,704	$36K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	318	$35K
96415		<1%	418	$35K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	312	$35K
62321		<1%	137	$34K
64405		<1%	377	$33K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,560	$32K
62370		<1%	1,514	$32K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	102	$31K
64450		<1%	374	$30K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	338	$29K
95811		<1%	77	$28K
00731		<1%	389	$28K
36591		<1%	2,375	$28K
J0586	Injection, abobotulinumtoxina, 5 units	<1%	91	$27K
36415	Collection of venous blood by venipuncture	<1%	16,796	$27K
97535	Self-care/home management training, each 15 minutes	<1%	654	$26K
92522		<1%	297	$23K
87641		<1%	984	$23K
87400		<1%	899	$22K
64495		<1%	143	$20K
64491		<1%	98	$20K
99205	Prolong outpt/office vis	<1%	133	$20K
77002		<1%	606	$19K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,659	$17K
97161		<1%	323	$17K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	422	$17K
64400		<1%	835	$17K
64633		<1%	25	$16K
86710		<1%	546	$16K
62368		<1%	332	$13K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	661	$13K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,537	$13K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	227	$12K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	563	$12K
80061	Lipid panel	<1%	1,770	$12K
94060		<1%	1,597	$12K
00813		<1%	128	$11K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,285	$10K
71046	Radiologic examination, chest; 2 views	<1%	1,090	$10K
94726		<1%	1,674	$10K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,796	$9K
95886		<1%	186	$9K
82728		<1%	1,008	$9K
97032		<1%	838	$9K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,461	$8K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,511	$8K
84481		<1%	644	$8K
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	1,127	$8K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	178	$8K
94729		<1%	1,711	$8K
81025		<1%	1,153	$8K
82607		<1%	717	$7K
84439		<1%	1,157	$7K
78815	Positron emission tomography (PET) for limited area imaging	<1%	15	$7K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,352	$7K
87430		<1%	444	$7K
82948		<1%	1,501	$7K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	232	$6K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	5,788	$6K
64642		<1%	96	$6K
96417		<1%	65	$6K
88307		<1%	80	$6K
94761		<1%	74	$6K
73221		<1%	51	$5K
81001		<1%	2,506	$5K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,185	$5K
86140		<1%	1,419	$5K
72141		<1%	44	$5K
83540		<1%	1,153	$4K
96367		<1%	128	$4K
87186		<1%	748	$4K
83550		<1%	876	$4K
87070		<1%	576	$4K
83880		<1%	259	$4K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,626	$4K
86677		<1%	341	$4K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	67	$4K
64492		<1%	16	$4K
85027		<1%	864	$4K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,122	$4K
97167		<1%	55	$4K
81003		<1%	2,933	$3K
87077		<1%	664	$3K
70486		<1%	59	$3K
71250		<1%	68	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	4,832	$3K
J3490	Unclassified drugs	<1%	5,464	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	72	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	72	$3K
86769		<1%	74	$3K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	15	$3K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	38	$3K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	481	$2K
00811		<1%	39	$2K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	41	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,443	$2K
95874		<1%	165	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	150	$2K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	29	$2K
85610		<1%	988	$2K
85007		<1%	945	$2K
83690		<1%	426	$2K
76536		<1%	39	$2K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	70	$2K
64634		<1%	17	$2K
82150		<1%	413	$2K
J2704	Injection, propofol, 10 mg	<1%	1,887	$2K
86756		<1%	136	$2K
64615		<1%	44	$2K
95806		<1%	42	$2K
86850		<1%	293	$2K
87205		<1%	514	$2K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	935	$2K
83735		<1%	484	$2K
85652		<1%	938	$2K
20611		<1%	29	$2K
20610		<1%	29	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	78	$2K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	12	$2K
72100		<1%	116	$1K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	70	$1K
90686		<1%	382	$1K
87075		<1%	129	$1K
92557		<1%	45	$1K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	27	$1K
73610		<1%	100	$1K
77066	Tomosynthesis, mammo	<1%	13	$1K
99406		<1%	351	$1K
87420		<1%	92	$1K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	14	$1K
85730		<1%	222	$1K
86900		<1%	350	$1K
82570		<1%	332	$953.89
94760		<1%	29	$928.00
86901		<1%	348	$927.58
97165		<1%	12	$913.66
72110		<1%	53	$910.90
83970		<1%	46	$875.44
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	13	$868.82
97163		<1%	14	$826.80
73110		<1%	51	$822.13
88304		<1%	87	$781.51
92567		<1%	60	$757.12
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	28	$732.85
76830	Ultrasound, transvaginal	<1%	12	$726.40
76642		<1%	19	$718.08
70450	Computed tomography, head or brain; without contrast material	<1%	13	$717.12
90674		<1%	34	$692.80
88342		<1%	26	$679.98
82784		<1%	48	$668.82
80076		<1%	105	$628.30
76770		<1%	15	$613.85
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	3,946	$597.99
94010		<1%	122	$587.69
29580		<1%	29	$573.05
99407		<1%	132	$547.15
83525		<1%	28	$546.10
73562		<1%	31	$537.50
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	27	$535.20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	32	$488.64
74019		<1%	38	$442.50
73630		<1%	44	$416.85
99401		<1%	13	$356.20
87807		<1%	28	$350.14
82746		<1%	40	$348.52
84702		<1%	19	$317.87
87480		<1%	18	$311.92
90656		<1%	87	$302.43
87660		<1%	17	$289.64
87510		<1%	17	$289.64
99442		<1%	68	$289.43
88141		<1%	14	$269.22
73140		<1%	13	$247.44
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	29	$240.05
85060		<1%	17	$207.42
74018		<1%	14	$190.51
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	26	$158.34
87340		<1%	18	$137.76
84100		<1%	54	$127.42
73130		<1%	15	$125.30
99443		<1%	13	$124.66
94664		<1%	35	$120.60
84550		<1%	39	$117.65
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	214	$116.07
82043		<1%	42	$110.64
G0008	Administration of influenza virus vaccine	<1%	139	$108.14
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	283	$104.05
82248		<1%	22	$99.04
85379		<1%	13	$90.40
J1170	Injection, hydromorphone, up to 4 mg	<1%	73	$85.35
36416		<1%	121	$84.00
82565		<1%	21	$79.80
86431		<1%	18	$73.75
82247		<1%	14	$66.84
87081		<1%	12	$59.70
73030		<1%	12	$57.99
80305		<1%	55	$57.13
84520		<1%	18	$57.07
82553		<1%	15	$53.53
84484		<1%	12	$45.59
82550		<1%	18	$43.90
J7050	Infusion, normal saline solution, 250 cc	<1%	123	$43.32
77063	Screening digital breast tomosynthesis, bilateral	<1%	179	$20.64
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	16	$19.76
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14	$5.92
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	27	$2.53
90461		0%	1,741	$0.00
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	0%	1,955	$0.00
90671		0%	573	$0.00
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	0%	1,241	$0.00
90633		0%	60	$0.00
90681		0%	102	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	210	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	239	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	226	$0.00
90670		0%	81	$0.00
99382		0%	109	$0.00
A4550	Surgical trays	0%	147	$0.00
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	0%	206	$0.00
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	0%	68	$0.00
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	0%	41	$0.00
A6204	Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing	0%	19	$0.00
A9577	Injection, gadobenate dimeglumine (multihance), per ml	0%	42	$0.00
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	0%	14	$0.00
A9270	Non-covered item or service	0%	2,153	$0.00
99381		0%	140	$0.00
90723		0%	451	$0.00
90647		0%	467	$0.00
S9088	Services provided in an urgent care center (list in addition to code for service)	0%	25	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	201	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	51	$0.00
91301		0%	15	$0.00
90716		0%	13	$0.00
99383		0%	23	$0.00
C9399	Unclassified drugs or biologicals	0%	14	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	143	$0.00
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	14	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	459	$-135.11

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialADAMSON, JAMES (CEO)